Results 71 to 80 of about 22,370 (168)

Beyond Fat Loss: Addressing the Sarcopenia Challenge of Incretin-Based Therapies. [PDF]

Diabetes Metab J
Kim JY, Kim NH.
europepmc   +1 more source

Tirzepatide Prescribing Practices and Efficacy in Patients with Diabetes and Chronic Kidney Disease at a Large Tertiary Care Center in the United States

Diabetes, Metabolic Syndrome and Obesity
Sriya Amruta Kosaraju,1 Rong M Zhang2 1Department of Biomedical Sciences, University of Missouri-Kansas City, Kansas City, MO, USA; 2Department of Medicine-Division of Endocrinology, Washington University, St Louis, MO, USACorrespondence: Rong M Zhang ...
Kosaraju SA, Zhang RM
doaj  

Correction: Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP/PS1 mouse model of Alzheimer's disease. [PDF]

Alzheimers Res Ther
Abdulhameed N, Babin A, Hansen K, Weaver R, Banks WA, Talbot K, Rhea EM.   +6 more
europepmc   +1 more source

Comments on Adverse Events Associated with Incretin-Based Therapies: A Narrative Review on Mechanisms, Clinical Management, and Risk Mitigation [Response To Letter]. [PDF]

Drug Des Devel Ther
Tobaiqy M, Alqutub ST.
europepmc   +1 more source

Limited Comparative Evidence Between Metabolic Bariatric Surgery and Incretin-Based Pharmacotherapy for Weight Loss in Type 2 Diabetes: A Systematic Review and Meta-Analysis. [PDF]

J Diabetes
Baniowdeh O, Arar A, Muslih Y, Obeidat T, Marji E, Elghandour S, Jbara J, Shengelia L.   +7 more
europepmc   +1 more source

Incretin-Based Therapies in Obesity-Related Obstructive Sleep Apnea: A Narrative Review of Evidence Tiers and Mechanistic Plausibility. [PDF]

Nat Sci Sleep
Zhang X, Jiang Y, Wei X, Wang S, Zhang X, Hu S, Shi L.   +6 more
europepmc   +1 more source

Practical considerations for the use of incretin mimetics in patients with neuroendocrine neoplasms: An expert consensus statement. [PDF]

Cancer
Grewal US, Ear PH, Sonbol MB, Bellizzi AM, Hofland J, Crona J, Dillon JS, Chan JA, Howe JR, Strosberg J, Singh S, Halfdanarson TR.   +11 more
europepmc   +1 more source

Beyond weight loss: Preserving muscle health in the incretin era. [PDF]

J Diabetes Investig
Imaizumi T, Yabe D.
europepmc   +1 more source

Adaptive maintenance after incretin-induced weight loss: Moving beyond the continue-or-stop paradigm. [PDF]

Obes Pillars
van Bruggen FH, Damhof MA, van Roon EN.
europepmc   +1 more source

Correction: Medical nutrition therapy in incretin-treated obesity-related heart failure with preserved ejection fraction. [PDF]

Front Nutr
Ming Q, Li Z.
europepmc   +1 more source